ClinicalTrials.gov
ClinicalTrials.gov Menu

INTERACTION, Monitoring of Stroke Patients in Hospital and Home Environment (INTERACTION)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02118363
Recruitment Status : Completed
First Posted : April 21, 2014
Last Update Posted : May 8, 2018
Sponsor:
Collaborators:
University of Twente
University of Pisa
Roessingh
XSens technologies B.V.
Smartex S.r.l.
Information provided by (Responsible Party):
University of Zurich

Brief Summary:
Clinical assessment and monitoring of balance and arm function in stroke patients with sensor based measurement, in clinical and home environment.

Condition or disease
Stroke

Study Type : Observational
Actual Enrollment : 8 participants
Observational Model: Case-Control
Time Perspective: Prospective
Official Title: Proof of Concept Study of the INTERACTION Technology, Monitoring of Stroke Patients in Hospital and Home Environment
Study Start Date : April 2014
Actual Primary Completion Date : December 2017
Actual Study Completion Date : December 2017

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. proof of concept [ Time Frame: 3 month ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 99 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
subakut or chronic stroke patients
Criteria

Inclusion Criteria:

  • Age: 18 or above
  • Previous Stroke in the personal history
  • Able to walk 10 meters. A walking aid (unilateral or bilateral) is permitted
  • Able to walk without special shoes
  • Able to raise the arm against gravity
  • Able to read and understand questionnaires and able to execute commands
  • Able and willing to participate in the study
  • Singed Informed Consent

Exclusion Criteria:

  • Contraindications on ethical grounds (vulnerable persons)
  • known or suspected non-compliance, drug or alcohol abuse,
  • Severe aphasia
  • Severe dementia
  • Severe depression
  • Relevant medical disease or increased risk of rehospitalization
  • Severe sensory deficits
  • Severe neglect

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02118363


Locations
Switzerland
Cereneo
Vitznau, Switzerland, 6354
Sponsors and Collaborators
University of Zurich
University of Twente
University of Pisa
Roessingh
XSens technologies B.V.
Smartex S.r.l.

Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: University of Zurich
ClinicalTrials.gov Identifier: NCT02118363     History of Changes
Other Study ID Numbers: 13101
seventh framework programme ( Other Grant/Funding Number: 287351 )
First Posted: April 21, 2014    Key Record Dates
Last Update Posted: May 8, 2018
Last Verified: May 2018

Keywords provided by University of Zurich:
upper limb
lower limb
monitoring
assessment
sensor

Additional relevant MeSH terms:
Stroke
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases